# Soley Therapeutics funding rounds and investors

As of 14 Oct 2026, Soley Therapeutics has raised $200M across 1 verified round on record; latest: $200 million Series C, announced 7 Jan 2026.

Soley Therapeutics is a biotech company that discovers and develops novel medicines by leveraging the sensing capabilities of human cells.

Website: https://soleytherapeutics.com  
Headquarters: South San Francisco  
Page: https://fireround.dev/companies/soleytherapeutics.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-01-07 | Series C | $200 million | not stated | Breyer Capital, Doug Leone Family Fund, GordonMD Global Investments, HRTG Partners, RWN Management, Surveyor Capital (a Citadel company) | [soleytherapeutics.com](https://soleytherapeutics.com/soley-therapeutics-announces-200-million-series-c-financing-to-propel-lead-oncology-programs-into-the-clinic-and-scale-its-cell-stress-sensing-platform), [businesswire.com](https://www.businesswire.com/news/home/20260107488410/en/Soley-Therapeutics-Announces-%24200-Million-Series-C-Financing-to-Propel-Lead-Oncology-Programs-into-the-Clinic-and-Scale-Its-Cell-Stress-Sensing-Platform) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.